Capricor Therapeutics | CAPR - Current Assets


Capricor Therapeutics reported $283.09M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 283.09M 39.85M Mar/2026
Cipla INR 241.47B 7.71B Mar/2026
Cytokinetics USD 839.46M 77.51M Mar/2026
Geron USD 498.53M 21.74M Mar/2026
Grifols EUR 5.96B 316.31M Dec/2025
Immunic USD 188.76M 165.89M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Prothena USD 339.2M 24.01M Mar/2026
PTC Therapeutics USD 2.25B 19.94M Mar/2026
Sarepta Therapeutics USD 2.31B 228.06M Mar/2026